De novo design of miniprotein drug conjugates targeting NECTIN-4 for cancer therapy
Acta Pharmaceutica Sinica B · 2026-09
DOI: 10.1016/j.apsb.2026.08.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-09. Verfasst von Ningning Wang und 15 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
Zitieren
APA
Wang, N., Xue, T., Li, N., Xiao, W., Ding, Y., Li, Y., Tang, G., Yang, Z., Zhao, Y., Pan, J., Jian, Z., Ju, Z., Tang, J., Cao, L., Liang, S., & Yu, B. (2026). De novo design of miniprotein drug conjugates targeting NECTIN-4 for cancer therapy. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.08.031
Vancouver
Wang N, Xue T, Li N, Xiao W, Ding Y, Li Y, et al. De novo design of miniprotein drug conjugates targeting NECTIN-4 for cancer therapy. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.08.031
BibTeX
@article{Wang2026,
author = {Wang, Ningning and Xue, Tianshui and Li, Na and Xiao, Weiling and Ding, Yanhong and Li, Yunting and Tang, Gaoyan and Yang, Zhizhou and Zhao, Yifei and Pan, Jinheng and Jian, Zhaocheng and Ju, Zhenyu and Tang, Jinbao and Cao, Longxing and Liang, Shujuan and Yu, Bowen},
title = {De novo design of miniprotein drug conjugates targeting NECTIN-4 for cancer therapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.08.031}
}
EUVIMED